Get started
Solid Biosciences Inc.Solid Biosciences Inc.Solid Biosciences Inc.

Solid Biosciences Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

SLDB chart


Full chart

SLDB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪265.80 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.04 USD
Net income (FY)
‪−124.70 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪64.40 M‬
Beta (1Y)
1.59

Employees


Employees (FY)
100
Change (1Y)
+12 +13.64%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.25 M‬ USD

About Solid Biosciences Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Alexander Gery Cumbo
Website
solidbio.com
Headquarters
Charlestown
Founded
2013
FIGI
BBG00JN4FXG8
Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SLDB news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as SLDB.

Frequently Asked Questions


The current price of SLDB is 3.43 USD — it has increased by 13.20% in the past 24 hours. Watch Solid Biosciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Solid Biosciences Inc. stocks are traded under the ticker SLDB.
SLDB stock has risen by 23.40% compared to the previous week, the month change is a −26.24% fall, over the last year Solid Biosciences Inc. has showed a −61.24% decrease.
We've gathered analysts' opinions on Solid Biosciences Inc. future price: according to them, SLDB price has a max estimate of 20.00 USD and a min estimate of 11.00 USD. Watch SLDB chart and read a more detailed Solid Biosciences Inc. stock forecast: see what analysts think of Solid Biosciences Inc. and suggest that you do with its stocks.
SLDB reached its all-time high on Jun 19, 2018 with the price of 822.60 USD, and its all-time low was 1.81 USD and was reached on Oct 30, 2023. View more price dynamics on SLDB chart.
See other stocks reaching their highest and lowest prices.
SLDB stock is 17.05% volatile and has beta coefficient of 1.59. Track Solid Biosciences Inc. stock price on the chart and check out the list of the most volatile stocks — is Solid Biosciences Inc. there?
Today Solid Biosciences Inc. has the market capitalization of ‪265.80 M‬, it has decreased by −5.56% over the last week.
Yes, you can track Solid Biosciences Inc. financials in yearly and quarterly reports right on TradingView.
Solid Biosciences Inc. is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
SLDB earnings for the last quarter are −1.00 USD per share, whereas the estimation was −0.80 USD resulting in a −24.23% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Solid Biosciences Inc. earnings.
Solid Biosciences Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SLDB net income for the last quarter is ‪−42.60 M‬ USD, while the quarter before that showed ‪−32.73 M‬ USD of net income which accounts for −30.17% change. Track more Solid Biosciences Inc. financial stats to get the full picture.
No, SLDB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 100 employees. See our rating of the largest employees — is Solid Biosciences Inc. on this list?
Like other stocks, SLDB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Solid Biosciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Solid Biosciences Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Solid Biosciences Inc. stock shows the sell signal. See more of Solid Biosciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.